1. Home
  2. TARS vs HE Comparison

TARS vs HE Comparison

Compare TARS & HE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • HE
  • Stock Information
  • Founded
  • TARS 2016
  • HE 1891
  • Country
  • TARS United States
  • HE United States
  • Employees
  • TARS N/A
  • HE N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • HE Electric Utilities: Central
  • Sector
  • TARS Health Care
  • HE Utilities
  • Exchange
  • TARS Nasdaq
  • HE Nasdaq
  • Market Cap
  • TARS 1.8B
  • HE 1.9B
  • IPO Year
  • TARS 2020
  • HE N/A
  • Fundamental
  • Price
  • TARS $40.65
  • HE $10.38
  • Analyst Decision
  • TARS Strong Buy
  • HE Hold
  • Analyst Count
  • TARS 7
  • HE 4
  • Target Price
  • TARS $67.14
  • HE $11.19
  • AVG Volume (30 Days)
  • TARS 552.3K
  • HE 1.5M
  • Earning Date
  • TARS 08-07-2025
  • HE 08-08-2025
  • Dividend Yield
  • TARS N/A
  • HE N/A
  • EPS Growth
  • TARS N/A
  • HE N/A
  • EPS
  • TARS N/A
  • HE N/A
  • Revenue
  • TARS $233,674,000.00
  • HE $3,171,906,000.00
  • Revenue This Year
  • TARS $122.94
  • HE $23.08
  • Revenue Next Year
  • TARS $44.14
  • HE $1.74
  • P/E Ratio
  • TARS N/A
  • HE N/A
  • Revenue Growth
  • TARS 449.03
  • HE 0.66
  • 52 Week Low
  • TARS $20.08
  • HE $7.61
  • 52 Week High
  • TARS $57.28
  • HE $18.19
  • Technical
  • Relative Strength Index (RSI)
  • TARS 40.26
  • HE 46.52
  • Support Level
  • TARS $39.25
  • HE $10.20
  • Resistance Level
  • TARS $42.01
  • HE $10.81
  • Average True Range (ATR)
  • TARS 1.93
  • HE 0.23
  • MACD
  • TARS -0.05
  • HE -0.04
  • Stochastic Oscillator
  • TARS 22.95
  • HE 34.85

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About HE Hawaiian Electric Industries Inc.

Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.

Share on Social Networks: